At a recent Revvity Signals Connect+ event, Eli Lilly's Douglas Stack and Alycia Hargraves unveiled groundbreaking ways the pharmaceutical company has advanced data management, streamlined compliance, and elevated collaboration. Joined by Colin Fyffe from Revvity Signals, the session explored cutting-edge integrations and practical insights shaping the future of pharmaceutical research workflows.